Department of Medical Laboratory Science, College of Health Sciences, Bowen University, Iwo, Osun State, Nigeria.
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Oyo State, Nigeria.
Afr Health Sci. 2024 Mar;24(1):10-15. doi: 10.4314/ahs.v24i1.3.
Haematological abnormalities are common among tuberculosis patients but there is dearth of information on their value as prognostic markers in Multidrug resistant tuberculosis patients. This study examined the association between complete blood count variables and drug resistant tuberculosis.
Nighty (90) consenting adults comprising 30 Drug Resistant Tuberculosis patients (DR-TB), 30 Drug susceptible tuberculosis patients (DS-TB) and 30 healthy participants were recruited in this study. Ethical approval was obtained from Oyo State Ministry of Health Institutional Review Board while patients' demographic data were collected using structured questionnaire. Five milliliters (5mL) of blood samples were collected in EDTA bottle. Haematological parameters were analysed using impedance technique and Mindary-BG5380 5-part automated system.
The mean hemoglobin levels were significantly lower in DR-TB patients (11.70 ± 2.73 g/dL) than in DS-TB patients (8.33 ± 9.56 fL), with a mean difference of -3.37 ± 12.29 g/dL. The mean MCH and MCHC levels were also slightly lower in DR-TB patients (26.17 ± 3.44 pg and 30.41 ± 1.92 g/dL, respectively), but the differences were not statistically significant. The WBC count was similar in both groups (8.20 ± 3.80 × 10 /L and 8.45 ± 3.63 × 10 /L, respectively).
The mean hemoglobin levels were significantly lower in DR-TB patients than in DS-TB patients which may be due to the increased inflammation associated with DR-TB. The WBC count was similar in both groups, suggesting that the immune system is responding similarly to the infection in both DR-TB and DS-TB patients.
In the meantime, healthcare providers should be aware of these potential differences and use them to inform their diagnosis and treatment of patients with tuberculosis.
血液学异常在结核病患者中很常见,但关于其在耐多药结核病患者中的预后标志物价值的信息却很少。本研究探讨了全血细胞计数变量与耐药结核病之间的关系。
本研究共纳入 90 名同意参与的成年人,包括 30 名耐多药结核病患者(DR-TB)、30 名药物敏感结核病患者(DS-TB)和 30 名健康参与者。伦理批准获得了奥约州卫生部机构审查委员会的批准,同时使用结构化问卷收集了患者的人口统计学数据。采集 5 毫升 EDTA 瓶中的血液样本。使用阻抗技术和 Mindary-BG5380 五部分自动化系统分析血液学参数。
DR-TB 患者的平均血红蛋白水平(11.70 ± 2.73 g/dL)明显低于 DS-TB 患者(8.33 ± 9.56 fL),平均差异为-3.37 ± 12.29 g/dL。DR-TB 患者的平均 MCH 和 MCHC 水平也略低(分别为 26.17 ± 3.44 pg 和 30.41 ± 1.92 g/dL),但差异无统计学意义。两组的白细胞计数相似(分别为 8.20 ± 3.80 × 10 /L 和 8.45 ± 3.63 × 10 /L)。
DR-TB 患者的平均血红蛋白水平明显低于 DS-TB 患者,这可能是由于 DR-TB 相关的炎症增加所致。两组的白细胞计数相似,表明免疫系统对 DR-TB 和 DS-TB 患者的感染反应相似。
同时,医疗保健提供者应该意识到这些潜在的差异,并利用它们来指导他们对结核病患者的诊断和治疗。